A randomized phase II trial of echinomycin, trimetrexate, and cisplatin plus etoposide in patients with metastatic nonsmall cell lung carcinoma: an Eastern Cooperative Oncology Group Study (E1587).

A randomized phase II trial of echinomycin, trimetrexate, and cisplatin plus etoposide in patients with metastatic nonsmall cell lung carcinoma: an Eastern Cooperative Oncology Group Study (E1587). Cancer. 1998 Jan 15; 82(2):292-300.

View in: PubMed

subject areas

Adult
Aged
Aged, 80 and over
Antibiotics, Antineoplastic
Antimetabolites, Antineoplastic
Antineoplastic Agents
Antineoplastic Agents, Phytogenic
Antineoplastic Combined Chemotherapy Protocols
Carcinoma, Non-Small-Cell Lung
Cisplatin
Drug Administration Schedule
Echinomycin
Etoposide
Female
Humans
Infusions, Intravenous
Injections, Intravenous
Intercalating Agents
Lung Neoplasms
Male
Middle Aged
Prognosis
Quality of Life
Remission Induction
Survival Rate
Trimetrexate

authors with profiles

Philip Bonomi